- Home
- Mutual Funds
- UTI Mutual Fund
- UTI Healthcare Fund Regular Plan-idcw
Fund Overview of UTI Healthcare Fund Regular Plan-idcw
-
₹1,216.9 CrAUM
-
₹241.39NAV
-
2.25%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of UTI Healthcare Fund Regular Plan-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 13.12% | NA | 6.12% |
| 6 Months | 10.36% | NA | 12.92% |
| 1 Year | 11.01% | 11.01% | 6.04% |
| 2 Years | 31.80% | 14.80% | 24.93% |
| 3 Years | 95.05% | 24.94% | 25.71% |
| 5 Years | 94.98% | 14.29% | 19.91% |
| 7 Years | 303.22% | 22.04% | NA |
| 10 Years | 262.53% | 13.75% | 12.78% |
Compare UTI Healthcare Fund Regular Plan-idcw with other mutual funds in the same category
UTI Healthcare Fund Regular Plan-idcw
SBI Healthcare Opportunities Fund Direct Plan-growth
SBI Healthcare Opportunities Fund Direct Plan-idcw
Asset Allocation
equities
94.45%debt instruments
0.01%other assets or cash equivalents
5.54%UTI Healthcare Fund Regular Plan-idcw is one Equity mutual fund offered by UTI Mutual Fund. Launched on 28 Jun 1999, the fund aims Long term capital appreciation. Investment in equity instruments following a value investment strategy across the market capitalization spectrum. It manages assets worth ₹1,216.9 crore as on Sun May 31, 2026. The expense ratio stands at 2.25%. Fund Manager Manager EducationAbout UTI Healthcare Fund Regular Plan-idcw
The portfolio allocation consists of 94.45% in equities, 0.01% in debt instruments, 5.54% in other assets or cash equivalents.Managed by Kamal Gada, it has delivered a return of 11.01% in the last year, a total return since inception of 14.77%.
Choosing an appropriate which sip is best has a key part in long-term wealth creation.
Key Metrics of UTI Healthcare Fund Regular Plan-idcw
-
Standard Deviation16.64%
-
Sharpe Ratio1.15%
-
Alpha0.95%
-
Beta0.96%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund Direct Plan-growth  |
₹4,566 | 1.67% | 13.30% | 10.49% | 24.74% | 16.80% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,566 | 1.67% | 13.30% | 10.49% | 24.74% | 16.80% |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth  |
₹6,454 | -1.21% | 11.20% | 7.32% | 26.34% | 16.48% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | -1.21% | 11.20% | 7.32% | 26.34% | 16.48% |
| Mirae Asset Healthcare Fund Direct-growth |
₹3,091 | -0.79% | 9.54% | 13.22% | 24.88% | 15.73% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹3,091 | -0.79% | 9.54% | 13.22% | 24.88% | 15.73% |
| DSP Healthcare Fund Direct-growth |
₹3,309 | 3.03% | 14.21% | 8.50% | 22.68% | 15.62% |
| DSP Healthcare Fund Direct-idcw |
₹3,309 | 3.03% | 14.21% | 8.50% | 22.68% | 15.62% |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | 1.58% | 13.02% | 9.38% | 23.45% | 15.57% |
| SBI Healthcare Opportunities Fund-idcw |
₹4,566 | 1.58% | 13.02% | 9.38% | 23.45% | 15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from UTI Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
UTI Healthcare Fund Regular Plan-growth
|
₹1,217 | 2.08% | 13.12% | 10.36% | 11.01% | 24.94% |
|
UTI Healthcare Fund Direct-growth
|
₹1,217 | 2.16% | 13.39% | 10.90% | 12.08% | 26.17% |
|
UTI Healthcare Fund Direct-idcw
|
₹1,217 | 2.16% | 13.39% | 10.90% | 12.08% | 26.17% |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹8,636 | ₹535.25 | 20.43% | 12.64% | 15.21% |
| Nippon India Pharma Fund Direct-growth |
₹8,636 | ₹601.05 | 21.51% | 13.66% | 16.24% |
| Nippon India Pharma Fund-idcw |
₹8,636 | ₹115.58 | 20.43% | 12.64% | 15.21% |
| Nippon India Pharma Fund Direct-idcw |
₹8,636 | ₹164.49 | 21.51% | 13.66% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,454 | ₹41.36 | 25.28% | 15.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,454 | ₹44.89 | 26.34% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,454 | ₹24.13 | 25.28% | 15.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | ₹27.11 | 26.34% | 16.48% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | ₹468.57 | 23.45% | 15.57% | 13.35% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,566 | ₹541.52 | 24.74% | 16.80% | 14.59% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.87% | ₹107.95 Cr |
| Net Current Assets | Unspecified | 5.54% | ₹67.43 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.87% | ₹59.21 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.70% | ₹57.20 Cr |
| Gland Pharma Ltd | Healthcare | 3.98% | ₹48.43 Cr |
| Lupin Ltd | Healthcare | 3.80% | ₹46.22 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.56% | ₹43.34 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.11% | ₹37.80 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 3.08% | ₹37.45 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.07% | ₹37.39 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.05% | ₹37.14 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.74% | ₹33.29 Cr |
| Procter & Gamble Health Ltd | Healthcare | 2.49% | ₹30.28 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.48% | ₹30.21 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.42% | ₹29.47 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.42% | ₹29.42 Cr |
| Sequent Scientific Ltd | Healthcare | 2.36% | ₹28.72 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.33% | ₹28.39 Cr |
| Marksans Pharma Ltd | Healthcare | 2.30% | ₹27.98 Cr |
| Global Health Ltd | Healthcare | 2.25% | ₹27.35 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹541.52 | 24.74% | 16.80% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹376.23 | 24.74% | 16.80% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹44.89 | 26.34% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.11 | 26.34% | 16.48% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.24 | 24.88% | 15.73% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.45 | 24.88% | 15.73% | - |
| DSP Healthcare Fund Direct-growth |
₹46.19 | 22.68% | 15.62% | - |
| DSP Healthcare Fund Direct-idcw |
₹26.71 | 22.68% | 15.62% | - |
| SBI Healthcare Opportunities Fund-growth |
₹468.57 | 23.45% | 15.57% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹295.17 | 23.45% | 15.57% | - |
growth is based on 5Y returns of the funds
Frequently Asked Questions
UTI Healthcare Fund Regular Plan-idcw
What is the current AUM of UTI Healthcare Fund Regular Plan-idcw?
As of Sun May 31, 2026, UTI Healthcare Fund Regular Plan-idcw manages assets worth ₹1,216.9 crore
How has UTI Healthcare Fund Regular Plan-idcw performed recently?
- 3 Months: 13.12%
- 6 Months: 10.36%
What is the long-term performance of UTI Healthcare Fund Regular Plan-idcw?
- 3 Years CAGR: 24.94%
- 5 Years CAGR: 14.29%
- Since Inception: 14.77%
What is the portfolio composition of UTI Healthcare Fund Regular Plan-idcw?
Equity: 94.45%, Debt: 0.01%, Others: 5.54%.
Who manages UTI Healthcare Fund Regular Plan-idcw?
UTI Healthcare Fund Regular Plan-idcw is managed by Kamal Gada from UTI Mutual Fund.
What is the market-cap allocation of UTI Healthcare Fund Regular Plan-idcw?
Large Cap: 26.33%, Mid Cap: 23.21%, Small Cap: 50.46%.
Which are the top companies UTI Healthcare Fund Regular Plan-idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 8.87% of the fund's portfolio
- Net Current Assets – 5.54% of the fund's portfolio
- Divi's Laboratories Ltd – 4.87% of the fund's portfolio
- Ajanta Pharma Ltd – 4.70% of the fund's portfolio
- Gland Pharma Ltd – 3.98% of the fund's portfolio
Which are the major sectors UTI Healthcare Fund Regular Plan-idcw focuses on?
- Healthcare – 63.87% of the fund's portfolio
- Unspecified – 5.54% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
